Masimo Radical® with SET Better than Nellcor N-600 with OxiMax, GE TruSat at Measuring SpO2 during Motion, Low Perfusion June 25, 2012 Masimo (NASDAQ: MASI) announced today a new study in the Journal ...
Masimo's SET pulse oximetry technology lessens measurement errors found in other types of pulse oximeters, and offers greater accuracy during patient low perfusion, an important consideration when ...
Powered by Masimo SET ® pulse oximetry, the Eve CCHD Newborn Screening Application is designed to simplify the CCHD screening process by providing step-by-step visual instructions, animations, and a ...
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...
IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the release of MX-7™, its latest and most advanced rainbow SET® board. Designed for integration into the more than 200 ...
Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Noting that OSA “can only be reliably diagnosed using multichannel sleep studies, which are expensive, demanding for families and only available in specialist centres,” Dr. Hill and colleagues at the ...
Masimo CorporationMASI announced that it has amended its royalty agreement with Nellcor. The agreement was originally inked by the two parties in Jan 2006. Per the amended agreement, Medtronic will ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results